Pediatric Vaccine Hesitancy: Causes and Intervention

Dear Colleagues,

The World Health Organization (WHO) identified vaccine hesitancy as among the 10 most important global health threats. This phenomenon represents a delay in acceptance or refusal of vaccines despite the availability of vaccination services. As per the WHO, vaccine hesitancy is based largely on confidence in the effectiveness and safety of vaccines, complacency, and convenience. In addition, there are a number of barriers to vaccination, such as individual, contextual (historical, socio-cultural, economic, political, environmental), and vaccine-related factors. Evidence suggests that many parents continue to feel hesitant about childhood vaccination. This has been fueled by low coverage of COVID-19 vaccines globally, through social media and other informal channels of communication.

In this Special Issue, we aim to provide a broader picture of the causes and driving elements behind childhood vaccine hesitancy and ways to remedy this phenomenon presented as original research articles. We are soliciting original articles up to 5,000 words in length (Introduction to Conclusion) based on any qualitative, quantitative, or mixed-methods study designs. Qualitative studies include research conducted with focus groups and/or interviews. Quantitative studies include observational (descriptive, cross-sectional, case–control, or cohort studies) or intervention research (cluster-randomized trial, field trial, randomized or non-randomized interventions). Mixed-methods studies combine qualitative and quantitative approaches.

Dr. Tatjana Gazibara
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.